NCT01290302 2025-06-12Blinded Cross-Over Bioequivalence (BE) Trial of Luitpold Azacitidine vs VidazaAmerican Regent, Inc.Phase 1 Completed38 enrolled 14 charts
NCT02653976 2024-01-26A Phase 2 Study of SP-02L in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)Solasia Pharma K.K.Phase 2 Completed67 enrolled 13 charts
NCT00089284 2019-08-14Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHLNorthwestern UniversityPhase 1/2 Terminated30 enrolled 12 charts